Showing posts with label Asthma. Show all posts
Showing posts with label Asthma. Show all posts

Thursday, 17 October 2019

The NYCE guideline for viral induced wheeze - Let's clear a few things up

If you’re unsure about how to manage viral wheeze in children, you’re not alone.  There is much confusion about this common paediatric presentation.  The uncertainty about best management exists for several reasons.
  • Research: The research on interventions is usually age based rather than specific to the condition being treated.
  • Guidelines: There are very few guidelines specifically for viral induced wheeze.  No national guidelines exist.  Some centres use asthma guidelines for acute treatment of viral wheeze while some develop  local guidelines which have significant variations.  
  • Front-line: There is often uncertainty about the diagnosis.  Telling the difference between bronchiolitis, vial induced wheeze and asthma/multi-trigger wheeze can be a challenge.

When you see a wheezy child, you want answers to all these questions.  So here we go, one at a time.

Question 1 – Does this child have viral induced wheeze?
If the child in front of you is snotty and between the ages of 12 months and 5 years then the answer is “almost certainly.”  Almost is somewhat unsatisfactory so here is the breakdown of that statement.

Wheezy children under the age of 12 months usually have bronchiolitis, a condition that is also induced by a virus but involves wetness of the small airways rather than bronchospasm of the larger airways.

Wheezy children over the age of 5 years might still have viral induced wheeze but asthma is a more significant possibility in this age group.  Children under the age of five may also get wheezy with other triggers but there is debate about what this should be called (e.g. multi-trigger wheeze) and when a diagnosis of asthma is given under the age of five it can easily turn out to be wrong.

The most certainty about the diagnosis of viral induced wheeze exists in those children between the age of 12 months and 5 years who
  • Only wheeze with a viral illness
  • Have a relatively rapid onset of wheeze
  • Have demonstrated response to beta-agonist treatment

It is worth knowing that there are wheezy presentations in this age group that can look a lot like viral wheeze.  These include bronchomalacia, acute allergy, and cardiac failure due to e.g. acute myocarditis.

Question 2 – What and how much treatment should I give to a child with viral induced wheeze?
Treatment of acute viral wheeze is often extrapolated from asthma guidelines.  Most, such as the BTS guidelines, stratify according to severity, mainly based on signs of increased work of breathing.

Other factors to consider include the child’s previous history of wheezy episodes.  It is reasonable to treat children who have progressed to needing a critical care level of treatment on previous occasions more aggressively in terms of treatment and more cautiously in terms of admission.

It is also well worth considering is whether the child has received effective treatment prior to presentation.  If the child has either been given no inhaled beta-agonists at home or the delivery has been ineffective, they are more likely to respond to a more conservative dose of inhaled treatment.  If they have been given substantial and effective treatment at home and are working hard to breate despite this, they are more likely to need a larger number of puffs to achieve an improvement.

Here is an example of how to treat an acute viral wheeze at presentation to primary care:





































The use of oral steroids in children with viral wheeze is controversial.  Much of the available research looks at wheezing within an age group, not categorising children into phenotypes of underlying cause.  This has led to age based approaches by some and a selective approach to using steroids by others.

The best evidence (1) for the use of oral steroids for viral wheeze between the ages of 1 and 5 would suggest that the following group are most likely to have a small benefit:
  • Children with a diagnosis of asthma
  • Children who have required substantial amounts of inhaled beta-agonist prior to presentation
  • Children whose severity and lack of response to treatment with beta-agonists requires admission to hospital

One simplified application of this evidence is to say that if the child does not have asthma and does not require in-patient treatment, there is too little evidence to support the routine use of oral steroids.  Note that a family history of atopy, though often used in decision making here, is not an indicator that the child is likely to benefit from steroids.

Question 3 – Should this child be admitted?
The answer to that will depend on various factors including clinical setting and local infrastructure.  In an urban primary care/ secondary care model, admission should be the norm in the pre-hospital setting for children with a moderatel or severe episode who have required significant quantities of salbutal and are not responding well. 

Children whose severity is judged to be mild, and those who are moderate at presentation but respond well to their first dose on inhaled beta-agonist can usually be managed in the community.

Risk factors such as prematurity, comorbidities, pervious life-threatening episodes, parental confidence/competence and adverse social circumstances should all be involved in this important decision.

Question 4 – How much beta-agonist should the parents give if I am sending them home?
There is huge variation in practice here.  Experience tells us that paradoxically children tend to need larger doses of inhalers rather than standard or small doses.  This is likely to be due to a combination of delivery (getting all that is given to where it will count) and physics, since children’s airways have different flow dynamics to adult airways.
The majority of clinicians will recommend that the child receives 6-10 puffs of salbutamol 3-4 hourly.  Note that local guidelines vary in terms of dose and interval.  There is a certain amount of clinical judgement involved which will be influenced by the presentation and the circumstances (including the parental confidence and competence with delivery of inhalers and their ability to recognise markers of deterioration.)

What guidelines often fail to explain are the aims of treatment at home.
  • To get the child’s breathing looking normal or nearly normal
  • To maintain that improvement for at least a couple of hours and ideally four hours
  • To prevent the viral wheeze from affecting the child’s activity, ability to feed etc.

It is useful to tell parents that the inhalers will not treat the symptoms of the viral illness such as cough and runny nose.

Treatment failure is generally considered to be:
  • Significantly increased work of breathing despite inhaled beta-agonists
  • Worsening severity – progressively requiring more puffs or more puffs at shorter intervals
  • Parental global concern about the appearance or wellness of the child

A further variation in practice is how people manage the issue of reducing/ stopping the inhaled beta-agonist treatment.  Viral wheeze is by definition a time limited problem.  As the effect of the virus and the child’s immune response resolve, so does the bronchospasm.  There are two main approaches to the way that people advise how to move towards stopping the inhaler.
  • A set weaning regime – many centres have a planned weaning regime for inhalers that is given to parents.  This sets out a planned reduction of the number/ frequency of inhaler given to the child.  It is usually written down and given to the parents for them to follow.
  • A weaning plan that is not prescriptive – it is equally common to give parents a plan that puts them in the driving seat.  Often, it recommends a set dosing and interval for a set period (e.g. 6 puffs four hourly for two days) to be followed by a period of using the inhaler when it is apparent that the child would benefit (e.g. increased work of breathing or audible wheezing).

Each approach has pros and cons.  A set weaning regime carries a risk that the parents will follow it even when the child is not ready.  A weaning regime that requires parental judgement carries a risk that the inhalers will continue to be given when not needed (e.g. to treat a cough) or that the parents will simply stop after two days and not recognise the child’s need for further inhalers.

Whichever approach is used, the risks can be managed by careful explanation of what to do, how to do it and when to divert from the plan.

It's important to know the uncertainties and variations in practice.  It's also important to have a guideline.  Viral wheeze has always been a paradox in that regard.  There is a broad concensus that viral wheeze is not asthma, yet there has always been a tendency to shoe-horn the management of viral wheeze into asthma guidelines.  Perhaps it is time that viral wheeze had its own guideline.  Wouldn't that be NICE.

Edward Snelson
@sailordoctor
References
  1. Foster S et al, Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial, Lancet, Vol 6, Issue 2, P97-106, Feb 01, 2018

Wednesday, 12 December 2018

Making the Right Judgement - a comprehensive 3D model for deciding what to do with each child with a respiratory presentation

In the previous post, I covered how best to make a diagnosis of lower respiratory tract infection (LRTI).  Anyone who has the pleasure of working with acutely ill children knows, the diagnosis is only a small part of what we do.  A big part of what we do is making that all important decision - home or hospital?

This decision is usually made up of several elements.  What is interesting is that the same principles can be applied to all of the major respiratory problems that we see, namely:
  • Bronchiolitis
  • Viral Wheeze
  • Asthma
  • Croup
  • Pneumonia (LRTI)
Once one of these diagnoses has been made, the decision about whether to admit or manage at home is a huge one.  On the one hand, we don't want to admit children to hospital unnecessarily.  Apart from the inconvenience and stress to the family, there is a significant risk of adding insult to injury as so many children who attend hospital acquire additional infection.  On the other hand, we know that if a respiratory problem does deteriorate, it can do so quickly and catastrophically.  If there is a significant risk of a child going off, they should be somewhere that can respond appropriately.

In the majority of childhood respiratory illnesses, the treatment itself is not what requires the child to be in hospital.  It is no longer routine to have a chest X-ray and intravenous antibiotics for uncomplicated community acquired pneumonia. (1)  Many children who are admitted with pneumonia receive no investigations and are treated with oral amoxicillin and discharged when they show improvement.  Severe croup is often a waiting game.  Viral wheeze is usually treated with inhalers via spacer.  Babies with bronchiolitis are often observed while a team of expert paediatricians avoid the temptation to "try something" that research has proven to be pointless.  You get the picture.  These are the times that paediatrics is the art of masterful inactivity.  Believe me, that is harder than it sounds and is actually quite labour intensive when done properly.  The point is, they still need to be there, because these are the children who, if they got worse, would require escalation of treatment.

So if the need for hospital specific treatment isn't always the thing that determines the need for admission, what else is?  In illnesses that always need hospital treatment (e.g. Kawasaki Disease) the decision is made for you.  However in respiratory problems that can be treated in the community, the decision is mostly about risk assessment, which is never as simple as people make it sound.

Guidelines often imply that the assessment of a respiratory presentation is a simple matter of deciding severity or calculating a score.  I like an over-simplification as much as the next clinician, except when it doesn't work, which is fairly often.  Why isn't it that simple?  Because not a one dimensional assessment.  The good news is, it's not that complicated,  It's just 3D instead.

D1 - Severity

The first dimension of the assessment is to decide severity.  All acute respiratory problems, like chain coffees, come in small medium and large.  Deciding which presentation fits into mild moderate or severe is fairly intuitive and the same principles apply across the different diseases.
Severe makes the decision easy.  Severe needs to be treated in hospital for several reasons.  Severe is usually a set piece, and although severe can be terrifying, it's not usually a cause of decision fatigue.  That comes from deciding what to do with the rest of them.

In a previous post, I shared some thoughts on croup scores and severity.  You can read that via this link if it would be helpful.

Mild cases of croup, bronchiolitis, viral wheeze, asthma and LRTI are almost always best managed at home.  Almost.  Moderate cases can often go either way.

D2 - Risk factors

This means that other factors are involved in the decision.  Because we are assessing risk, we need to consider risk factors.  These, when applied to the severity of the illness literally multiply the risk of something bad happening.
As a rule, a risk factor alongside a moderate severity of respiratory problem is ore than enough to mandate admission to hospital.   That child with croup that you were thinking of sending home- I suspect that decision will be changed when you factor in the fact that they were born prematurely at 26 weeks.

What is slightly more complicated is how risk factors apply to the child with a mild presentation.  It's complicated because the presence of a risk factor does still ramp up the risk, but its a factor applied to a very small risk in the first place.  What's more, the same risk factors that apply to the presentation also apply to the risk of being in hospital.  An ex-premature baby with mild bronchiolitis could go off, but the risk is still small.  An ex-prem baby in hospital if they don't need to be is a risk all of its own.

The decision about what to do with a child who has a mild respiratory problem but also has risk factors is a difficult one.  It is a decision best made by an experienced clinician who understands the way that the particular risk factor interacts with the illness and knows the pitfalls associated with it.  If you're not sure, refer or discuss the case.  This may be a good opportunity for an experienced primary care clinician to share that decision with an experienced paediatician via a telephone consultation.

D3 - Red Flags

Finally, there are red flags.  Although independent of the apparent severity of the presentation, these features will usually mandate referral or admission.

A good example of a red flag feature would be a 4 month whose clinical examination is consistent with mild bronchiolitis.  If the accompanying adult says that the infant had an episode of suddenly becoming pale and floppy earlier that day, this should be treated as a warning sign.
Bringing those three dimensions together will give you the answer to the "home or hospital?" question.  It will also help the communication between primary and secondary care.  Referring a child with a respiratory problem, summarised as diagnosis, severity, risk factors and red flags is just showing off.  There's nothing wrong with that is there?

Edward Snelson
Dimensional Relativist
@sailordoctor

Disclaimer: I'm never sure which is worse: oversimplification or undersimplification.

References
  1. Guidelines for the management of community acquired pneumonia in children: update 2011 British Thoracic Society Community Acquired Pneumonia in Children Guideline Group


Wednesday, 18 April 2018

Why Do Different Children Wheeze Differently? - Simple, but first you have to understand all of paediatrics (also simple)

When a child or young person has one or more wheezy episode, there are various possible causes.  The vast majority of paediatric wheeze is caused by bronchiolitis, viral wheeze and asthma.  It is easy to confuse these conditions, but clarity of diagnosis has real benefits when it comes to providing evidence based treatment.

We know that getting the diagnosis right isn't straightforward, possibly because there are no tests which reliably distinguish these entities from each other in children.  For example, evidence suggests that 50% of children diagnosed as asthmatic do not have asthma (1).  One knock-on effect of any diagnostic difficulties is that people make up rules for us.  "Asthma should not be diagnosed under the age of 5 years."   "Inhalers don't work under the age of 12 months."   These rules are meant to be helpful, but they are both wrong.  If you were only playing the odds, living by these rules would be the way to go, but clinical medicine is also about pattern recognition.  If it looks like a duck etc.
I think that it is possible to embrace the rules, while also knowing when to break them.  I believe that there is a simple model for understanding paediatric wheeze which fits into the probability model and the pattern recognition model.  It's fairly simple and all it requires is a good understanding of all of paediatrics.
Paediatrics isn't the art of learning 30,000 rare conditions.  Paediatrics is mostly about understanding what conditions affect children at different ages and how children respond to those illnesses.  That in turn allows us to recognise and treat appropriately wherever possible.  When it comes to infections and immune responses, unsurprisingly the immune system plays a big role.  Of course a child's immune system goes through several stages and each one dictates a different response to infection and allergens.

How does a baby fight infection?  In simple terms, they don't.  Inherited antibodies do most of the work for the first few months.  Few pathogens get past these antibodies and so the baby's own immune system does very little.  This has lots of implications.  Infections that do occur are unlikely to be common viral illnesses and whatever the pathogen, the baby will be at greater risk from that infection.  Even the recognition of an unwell baby is affected by their lazy immune response.  Temperature of 40C in a 7 day old?  Pull the other leg.
These maternal antibodies eventually run out.  The immune system has to learn and develop.  Older children, like adults have a complex and clever immune system which has stored a wealth of information about the pathogens in their environment.  This allows the older child to produce a response to infection that is not just complicated but sometimes over-complicated.
So how does a human survive in-between losing maternal antibodies and learning a more complex immune response?  In scientific terms, their immune system goes nuts.  You have seen it yourself: even with a relatively simple and uncomplicated viral infection, the younger child can have very high temperatures, various rashes and of course viral wheeze.  Other things that are common in this age group are quite possibly in part due to this exaggerated immune response - irritable hips and febrile convulsions.
These three ways of responding to infection align very nicely with the three entities that commonly cause wheeze at different ages in children.

So, the rules about age do have a solid basis.  Would you diagnose asthma when a six week old becomes wheezy?  Please don't.  Would you diagnose bronchiolitis in a 12 year old?  No.

Age alone does not give you the diagnosis since there is some overlap.  Thankfully, because each condition represents a different immune response, they each present with slightly different clinical features. As a result we can combine probability with pattern recognition.  The best bit is that the pattern recognition fits well with these three immunological stages of childhood.

What happens when you are a baby and a virus causes a respiratory tract infection?  In most cases, the answer is simply wetness.  Bronchiolitis is what you might expect from an immune system that has not yet fully woken up from its cocoon of maternal antibodies.  Bronchiolitis tends to slowly progress over days from cough and coryza to wheeze and suboptimal feeding, finally ending up with a variable degree of respiratory distress.  It progresses over days.  The severity and progression of these symptoms will vary from child to child, however the gradual onset is characteristic.  This is not to be confused with deterioration, which can be sudden, especially in high risk babies.

Viral wheeze by contrast tends to come on quickly, over hours rather than days.  This is because in viral wheeze is a different response to the same viral trigger.  In children between the ages of about 1 and 6, when the immune system sees a new virus, it tends to go a bit crazy.  One of the effects of this immuno-enthusiasm seems to be that that many children experience bronchospasm as part of that immune response.  So in addition to being able to tell which is more likely (bronchiolitis or viral wheeze) by the age of the child, the rapidity of the onset of the wheeze is a clue.
Why does it matter that we tell the difference?  These two different entities respond differently to treatment.  The slow development of inflammation and wetness in the airways that is bronchiolitis does not respond to bronchodilators while the bronchospasm of viral wheeze does.  This is probably the reason for the perpetuated myth that children under the age of one don't respond to beta-agonists.  They do, but only if they have bronchospasm (viral wheeze) as opposed to mostly wetness (bronchiolitis).

Finally, when your immune system moves from the "shoot first, ask questions later" mode into adult mode, asthma becomes the most common cause of wheezing in children and young people.  The trouble is that this isn't something that happens suddenly and it certainly isn't the case that there is a consistent age for this to happen.  Once again though, odds are very much affected by the age of the child.  Does the 8 month old have asthma?  No.  Does the 15 year old have episodic viral wheeze.  Almost certainly not.  Once again, the fact that the different entities represent different stages of immune system maturity translates into both probability and pattern recognition.  The 3 year old is probably having episodes of viral wheeze, but this will be confirmed by the fact that all episodes are precipitated by viral illnesses and the lack of interval symptoms.  The 10 year old probably has asthma and if this is the case they will be having episodes of wheeze not just when they get viral illnesses.

This explains the contradictions between all of the things that we know about asthma in children.  We are told that we shouldn't diagnose asthma under the age of five.  That rule works well from a probability point of view but not from a pattern recognition point of view.  What would you do if a 3 year old has a chronic cough and multiple episodes of wheeze that are not all provoked by viral illnesses?  I think that this child might be the exception to the probability rule.  Equally, in a 2 year old with chronic cough and no history of wheeze the temptation to diagnose asthma is a dangerous one given both the lack of  probability and the absence of a classic history.
Understanding the way that children respond to infection at different ages tells us a lot about where (what age) to look for each diagnosis and what to expect (the classic history) to find in order to confirm that diagnosis.  This allows us to maximise the chances of giving the most appropriate treatment, most of the time.

When there is a discrepancy, we need to be aware that probability and pattern have not agreed, and have a low threshold for rethinking.

Edward Snelson
Occasional rule analyst
@sailordoctor

Disclaimer: No-one understands all of paediatrics.  I mean really, who can explain why children will eat glue and drink air freshener but refuse to eat the food that you want them to eat?  That's why it's best to stick to the basics (like immunology) and leave the complicated stuff to the parents.

References
  1. Ingrid Looijmans-van den Akker, Karen van Luijn and Theo Verheij, Overdiagnosis of asthma in children in primary care: a retrospective analysis, Br J Gen Pract 2016; 66 (644): e152-e157




Tuesday, 28 March 2017

The Random Goldfish - When confirmation bias met affective bias


In the previous post, I explored how confirmation bias can lead us to believe that something is causing a problem when really it isn't.  Although sometimes unexpected, this kind of news is not unwelcome.  Finding out that fever doesn't really cause febrile convulsions is a surprise to many, but usually a good one.  Telling people that their treatments don't work is much less popular.

Anyone who has been a clinician for a reasonable amount of time knows what it feels like to share good and bad news with someone.  When I am teaching about paediatrics in primary care, it sometimes feels like I am saying that very few treatments actually work.  This feels having something taken away form us.  The real headline is that children make themselves better in the vast majority of clinical scenarios.  It is our job as clinicians to do as much nothing as possible while looking for opportunities to give effective treatments.

One question that I am often asked is, "If these treatments don't work, why do people use them?" Good question.  I tend to assume that my sample cohort of co-workers is representative of clinicians and I work with good, conscientious people who want to give children the best treatment possible. Since I don't believe that clinicians are generally unintelligent, malicious or lazy, I will take a risk and say that there must be powerful forces at work if any of us are giving ineffective medicines to children.  The problem that leads us all to use ineffective treatments is our very desire to make children better and parents happy.

If you want something really badly and do something in an attempt to make it come about, when the thing happens, we are likely to believe that this was cause and effect.  This approach would work in a fixed environment,  For example, consider a person trying to solve a puzzle (like a Rubik's Cube).  The puzzle isn't going to solve itself, so if the person tries many different strategies and then something works, they have solved the puzzle.  This assumes that the puzzle has not been solved by chance, which in this case is extremely unlikely.

Now consider someone with a different problem.  He wants a picture of his goldfish next to the castle in the goldfish bowl.  He tries shining a light to get the goldfish to move into position.  He tries tapping the glass, placing some food and tries making waves in the tank.  Whatever he does just before the goldfish moves into position must have done the trick right?  Wrong.

Well, much of paediatrics is like that.  Childhood symptoms often fluctuate or resolve.  We want our treatments to work.  We want to make children better and parents to be happy.  These factors are the perfect ingredients for us to wrongly believe that what we did worked.  Sometimes though, the goldfish just moves.  Because it's a goldfish.

Enough about goldfish. Let's use a really common example of how confirmation bias leads us and our patients to believe in an effect that is not real.

If I tell someone that antibiotics will cure a child's throat infection within a week, you can imagine how that sounds plausible.  Then, the initial belief in my statement will be reinforced when the child does indeed get better.  The true believer does not consider that the alternative is just as plausible - that all (uncomplicated) throat infections get better with time.  You know that guy who still has the viral sore throat he caught when he was two years old?  No?  Neither do I.

Paediatrics is a branch of medicine where most illnesses will resolve with time and many symptoms that could be attributed to a treatable cause.  But we and the parents both want the problem to be treatable.  The problem is, you're too nice.  You want to help and you want everyone to leave happy. This is called affective bias (the thing that reinforces confirmation bias). The end result is that we can easily believe that we are treating a problem, when in fact it gets better on its own.


Now, bias gets a bad name in medicine, but I would like to defend bias.  Clinicians could never learn or make decisions without bias.  We would be permanently uncertain and unable to choose. Without confirmation bias, we would never notice a pattern.  Without affective bias we would never take the parents seriously or care about the child.

Bias is good.  There, I've said it.

Bias is your friend, but friends can be fickle.  The thing about friends is that despite their faults, they're still your friends.  It is good to know what to expect from them.  That way, you don't feel surprised when they do the thing that they always do.  In the case of bias, your friend wants to mislead you and get you do do things you shouldn't do.

So, what are the best examples of the confirmation bias of presumed effect in paediatrics?  I've already mentioned antibiotics for upper respiratory tract infection.  There are many more, but lets just look at one in detail as an example:

Confirmation bias (presumed effect) - 
Example number 2: Treatments for gastro-oesophageal reflux disease in infants
If there was ever a paediatric condition that fitted the brief for this subject, it is feeding problems in babies.  The symptoms that babies present with are so often simply withing normal limits for infancy.   Did you know that straining is a thing that 1 in 6 babies do and that it is called dyschezia, not constipation?  If you add regurgitation of milk (aka 'reflux'), colic and other common gastrointestinal complaints, most babies have some sort of symptom that we could treat if we chose to during the first few months of life.  With a few exceptions, these are normal for being a baby, and will resolve in time.

The cardinal sign of a self resolving problem is that there are treatments available without good evidence of efficacy.  (Cough medicines for children are a good example of this.)  By way of contrast, there are very few treatment strategies for the management of pneumonia.  I'm guessing that you probably use antibiotics.

The evidence for the available treatments for reflux disease is not good.  In many cases the evidence is that they have little effect.  Rather than posting several dozen references, I am simply going to signpost you to the NICE guideline for Gastro-oesophageal reflux disease in children and young people. (1)  In the full document there is an extensive literature review which makes for interesting reading.  The bottom line is that the evidence is usually lacking.  The evidence that we do have form research points toward little or no effect for alginates, H2 agonists and PPIs.  By their own admission, much of the advice in the guideline depends on the experience of the experts involved in the guideline writing process.

Of course the problem is that there are infants with genuine pathology.  These children often begin their visits to healthcare professionals with non-specific presentations which easily fit the bill for what is 'normal for infancy'.  If we are honest with ourselves, the niggling doubt that the child might have a significant problem is one of the factors that pushes us in the direction of pulling out our prescription pads.  After all, it won't look as bad when the child turns out to have a problem later if we were busy trying treatments instead of reassuring the parent that these symptoms are usually part of normal infancy.

Avoiding unnecessary treatments is gold standard care.  Alginates are the most frequently used medications for reflux symptoms but in my experience this treatment runs a high risk of causing constipation.  This is far from ideal if you are trying to make life easier for baby and parent alike.   Motility drugs have repeatedly been associated with dangerous cardiac side effects and PPIs have been shown to increase the risk of respiratory tract infection. (2)  The take home message from this is that, although medication is an option, we need to be sure that a treatment is really likely to be better than watchful waiting.

The NICE guidelines focus on consideration of how the infant is affected - severe distress or red flags (faltering growth, feed refusal etc.).  It is also important to consider other possible diagnoses such as UTI.

I said that there were quite a few problems that have a similar story.  Going through all of them in detail would take a long time, but here is a list of some of the treatments that lend themselves to this combined bias effect:
The evidence for all of these treatments in children is that they work rarely (antibiotics for URTI, inhalers for cough alone, suspected CMPA based on colic alone) or never (cough syrups, simethicone or lactase for colic in babies).  All of these clinical scenarios share a common theme- the likelihood that the symptom will resolve in time.

So lets come back to bias.  Confirmation bias will cause us to believe that a treatment is effective while affective bias will make us want to give something even when there is little or no benefit. "But earlier, you said that bias is good.  You said that bias is my friend!" you might well say.  I stand by that.  As long as you know how you expect your friends to behave, any misbehavior can be managed and they can still be your friends.

For confirmation bias, we need to have good evidence to justify treatment that is used for symptoms when the natural course is resolution with time.  For example, I don't need evidence to back up my belief that morphine works for pain when a child has a broken leg.  If the child feels less pain afterwards, it has nothing to do with a goldfish effect.  Conversely, I should want evidence that a treatment is effective for any of the symptoms listed above.

For affective bias, we need to harness our desire to be nice to parents and children.  That means not wasting their time with ineffective treatments or worse still causing new problems. Sometimes, doing nothing is the nicest thing that you can do.  Managing to treat where appropriate and avoid unnecessary treatment is the holy grail of paediatrics.  Ultimately, the child is the patient and we need to only give them medication that is more likely to help than harm.  At least, that's what we should be trying to do despite our biases.

Edward Snelson
Amateur Medical Errorist
@sailordoctor

Disclaimer - I am too biased to be taken seriously, even by myself.



References
  1. NG1 - Guideline for Gastro-oesophageal reflux disease in children and young people, NICE
  2. Orenstein et al., Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease, J Pediatr. 2009 Apr;154(4):514-520


Tuesday, 3 January 2017

Your New Year's Resolution - Undiagnose a Child This Year

If you’re wondering what to do for your New Year’s resolution, don’t give something up or join a gym.  Neither will work out anyway.  This year, do something truly worthwhile - promise yourself that you will undiagnose a child or three.


Paediatrics is particularly prone to the pitfalls of overdiagnosis and overtreatment.  Although this is a problem, the reasons for overdiagnosis are actually good ones:


When there are no good tests available to tell between two possibilities, we sometimes give a therapeutic trial to help answer the question.  That is a strategy which will lead to misdiagnosis if symptoms improve despite our treatment rather than because of it.


With therapeutic trials, it is often best to challenge the assumption that it was the treatment that worked.   The two best examples that I can think of are childhood asthma and cow’s milk protein allergy in infants.

Let me give you a case to illustrate what I mean:

A 3 month old has been treated unsuccessfully for symptoms of gastro-oesophageal reflux disease (GORD).  A clinician suspects non-IgE Cow’s Milk Protein Allergy (CMPA) because first and second line treatment for GORD has been unsuccessful and because they notice that the baby has quite significant eczema.  (Click here to see a guide to diagnosing feeding problems in this age group)  The clinician decides to trial an extensively hydrolysed feed.  Over the next few weeks, the child’s symptoms of being unsettled and bringing back feeds improve considerably.  The eczema is responding to topical treatment.

In this situation, it is easy to assume that the change of milk was what made the difference.  Often, this is simply confirmation bias.  Colic, reflux and other symptoms of infancy have a tendency to self-resolve.  Of course the treatment may have been what worked but at this point in time, we genuinely have no idea.

This is the time to stop the hydrolysed formula and reintroduce a standard formula.  (Only do this for Non-IgE CMPA.  IgE CMPA is the kind that has urticaria and wheeze etc.  The children with this type of allergy need to be referred to an allergoligist.)   If the original symptoms of being unsettled and vomiting lots return in the next couple of weeks, the diagnosis is now more robust.  If the child remains well despite a return to standard formula, you have undiagnosed a thing.  Marvellous.


The second clinical scenario is the 7 year old with a nuisance cough.  The cough has been there for somewhere around 2-3 months.   There are no associated symptoms such as wheeze or altered exercise tolerance, but the cough is waking the family up at night.  The chest is clear on examination.

So, what is the likely diagnosis?  Surprisingly, in research land, coughs like this turn out to be caused by pertussis infection more often than asthma or reflux disease. (1,2)  It seems that although the pertussis vaccination is successful, infection is still relatively common.  Instead of causing a more significant respiratory illness, what we see in vaccinated children is often just the cough that lasts 100 days.  There are other, similarly benign reasons for chronic cough in children.  Also, there are plenty of significant pathological causes of chronic cough that are not asthma.

Diagnosing ‘cough variant asthma’ is possibly the biggest reason for the current debate about overdiagnosis of asthma in children, fuelled by an article in the BJGP earlier this year. (3)   Many children in the UK are prescribed inhaled steroids for chronic cough symptoms.  If they get better, this is taken as evidence that they had asthma, but there are other possible reasons for this resolution of symptoms.  The evidence suggests that the most likely thing is that the cough has resolved with time rather than with treatment.

This is therefore another opportunity to undiagnose a thing.  As well as stopping inhaled steroids after (Snelson makes up a number quickly…) three months it is probably a good idea to get some sort of objective assessment before, during and after the therapeutic trial.  Peak flows are great if you can get the child to do these well.  In many cases a symptom score (4) is more achievable.  If the only complaint was cough, then a symptom diary is all that is required.

If when you stop the steroids, the child’s cough is still resolved, you have a winner.  Your New Year's resolution is fulfilled.  Of course, once you start, undiagnosing an become a bit addictive.  If you find it becomes a problem, why not join a gym instead?

Edward Snelson
Diagnosectomist
@sailordoctor

Disclaimer: My New Year's resolution is to get a better disclaimer.

References:
  1. Marchmont et al, Evaluation and Outcome of Young Children With Chronic Cough, Chest Journal, May 2006, Vol 129, No. 5
  2. Wang et al, Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study, BMJ, 2014;348:g3668
  3. Looijmans-van den Akker et Al, Overdiagnosis of asthma in children in primary care: a retrospective analysis, BJGP, 1 March 2016
  4. Asthma.com, Child Asthma Control Test




Thursday, 13 October 2016

Why bronchiolitis doesn't get better with inhalers and how understanding "why?" is better than "do that!"

There was interesting debate this week about using inhalers for bronchiolitis.  The interesting features included how heated it became (there was mild name calling and much "prove it" involved, rated PG) and how confident people were in expressing their views on social media about their differing clinical practice.  (Take it from me that you should be fairly sure of yourself before you put something out onto the interweb.)  To me what was most interesting was that the views, despite being polar opposites, where seen as fact.  I am going to assume that all involved want to practice the best possible medicine, but someone must be wrong mustn't they?

What do the guidelines say?  The American Academy of Pediatrics and the UK's National Institution of Clinical Excellence along with other institutions, have produced guidelines in the past few years, specifying that beta agonists and ipratopium should not be used, so why are such debates still happening?  I think that there are a few reasons.  One of these is that for medics, knowing what to do is not as powerful as knowing why, especially when it comes to changing practice.  For me, understanding a disease is much more effective as a learning process than being told, "This is the disease and this is the treatment."   I suppose it is because I already understood the reason why I was doing what I was doing (even if the understanding was flawed), so a diktat is not as powerful a persuader as a new and better understanding.


There is a perpetuated myth regarding beta-receptors and infants.  This myth comes from early studies that failed to find evidence of beta-receptors in infants.  Since then, (as early as 1987) research of better methodology (3) has proven that these receptors are there from birth.  The myth persists because (just as the news reports plenty of crises but not so many resolutions) we are often told things, but rarely does anyone untell us something.

Perversely, the beta-receptor folklore has done us no favours when it comes to trying to understand bronchiolitis and viral wheeze.  The uncertainty created by this myth makes clinicians think that a lack of beta receptors has caused the lack of response to salbutamol.  In fact, the child would respond just fine if only they had bronchospasm.

In bronchiolitis, there is no bronchospasm so salbutamol does not help.  In viral wheeze, ipratopium is a poor treatment and the old myth about ipratropium leads some to believe that ipratropium is the first line treatment for this age group when what they really need is plenty of salbutamol if they really do have bronchospasm.

When discussing the management of wheeze in infants, I often get the impression that people believe that bronchiolitis is just what you call viral wheeze in a child under the age of 12 months.  In fact this is not true.  Bronchiolitis is a separate entity, with different histopathology and a unique clinical pattern of illness.  There is a gradual unset of symptoms, peaking at day 3-4 and beginning to resolve at day 7-10.  Doesn't sound very spasmy does it?

Of course the confusion arises from the fact that both bronchiolitis and viral wheeze are caused by a viral illness.  They can both occur in a child around the age of 12 months old and they cause similar symptoms.  There is however a subtle but helpful difference in the way that they present.

The reason for this difference is a difference in mechanism.  While bronchiolitis and viral wheeze share a cause, the pathology is different because the effects on the airways are different.


I suppose that since it is unrealistic to think that all uncertainty can be removed, the question remains, what is the harm in trying a bronchodilator in all every case, just in case?  Here are a few possible reasons why it is going to make things worse if it isn't going to make things better:


It's always difficult when two illnesses have so much overlap, but there are genuinely good reasons to avoid unnecessary treatment for bronchiolitis.  Hopefully understanding why bronchodilators don't work helps the thinking clinicians to decide for themselves, rather than just being told what to do by guidelines.

Edward Snelson
Mytharchivist
@sailordoctor


Disclaimer:  I would like to express my appreciation to the children who allowed me to perform lung biopsies on them during their wheezy episodes.  Science thanks you.


References
  1. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis, American Academy of Pediatrics, October 2014
  2. NG9 Bronchiolitis in children: diagnosis and management, NICE, June 2015
  3. A Prendiville et al., Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors, Thorax. 1987 Feb; 42(2): 100–104.

Wednesday, 2 March 2016

Asthma, Overdiagnosis, Underdiagnosis and all that

A storm is coming and it's set to be a force 10.  There is much debate about how asthma should be diagnosed in children.  There are two opposing views and (guess what?) they are both right.  This conundrum, which occurs whenever a diagnosis is complex, is always the perfect setting for the perfect storm as clinicians struggle with the "right way" to diagnose an illness.

This week an article was published in the BJGP, talking about the overdiagnosis of asthma.


Overdiagnosis is an issue close to my heart because it causes morbidity through tests, treatments and time spent being medicalised, none of which are necessary because the patient does not have the disease.  In paediatrics there is a particular tendency to overdiagnosis due to the lack of precise information (what does the abdominal pain feel like to a 2 year old? It would really help to know!) and the desire to make the child better.  Being cute will have that effect.

Of course overdiagnosis is also at risk of distracting from the real diagnosis, thus robbing the patient of treatment that would be beneficial.

The above mentioned article contains some results that will make most of us sit up and take notice. Set in the four Dutch primary care centres, they found that in "more one-half (53.5%, n = 349) of the children the signs and symptoms made asthma unlikely and thus they were most likely overdiagnosed."

Very well, so essentially this shows that when you apply a new diagnostic pathway (retrospective analysis of signs and symptoms plus a generous use of tests including spirometry), it disagrees with the old diagnostic pathway, which was presumably based mainly on history and examination.  That doesn't feel very applicable to the 'real world' of diagnosing childhood asthma in a front line clinical setting.  Well get ready, because your 'real world' may be about to be rocked.

Earlier this year, NICE published a draft guideline for the diagnosis of asthma, including children.  This contains one particular proposed recommendation that surprised me: "Do not use symptoms alone without objective tests to diagnose asthma. (in children from the age of 5)"  Boom.

So, a six year old comes in with an acute wheezy episode.  This was not triggered by a cold.  It started when they visited an animal shelter.  The child has eczema and the parents are both atopic. When you see them, the child responds to the salbutamol that you give.  In further history the parents had noticed that the child coughs at night quite a lot.  Time to do some tests?


I await the final version of the NICE guideline with interest.  Meanwhile I am a big fan of the British Thoracic Society guidelines which stratify into three groups - low, intermediate and high probability of asthma.  These guidelines list the features that make asthma more likely:
  • More than one of the following symptoms - wheeze, cough, difficulty breathing, chest tightness
  • Personal history of atopic disorder
  • Family history of atopic disorder and/or asthma
  • Widespread wheeze heard on auscultation
  • History of improvement in symptoms or lung function in response to adequate therapy.

And the features that make asthma less likely:
  • Isolated cough in the absence of wheeze or difficulty breathing
  • History of moist cough
  • Prominent dizziness, light-headedness, peripheral tingling
  • Repeatedly normal physical examination of chest when symptomatic
  • Normal peak expiratory flow (PEF) or spirometry when symptomatic
  • No response to a trial of asthma therapy
  • Clinical features pointing to alternative diagnosis

Testing with spirometry etc. is reserved for times of diagnostic subcertainty.

Does this approach lead to overdiagnosis?  I am sure that it does, for the reason that that children with intermediate probability of asthma still might not have asthma.  While tests can add to the available information, the diagnosis of asthma remains clinical.

So how bad is overdiagnosis?  If I could avoid overdiagnosis then I would, but in medicine that is just not possible unless there is a perfect test available.  In most cases we have to set ourselves the challenge of being rigorous with our diagnoses without being overcautious.  Cautiousnesses leads to underdiagnosis  which is also problematic, depending on the burden of the disease.  I am happy to overdiagnose sepsis in babies for example.  I know that the alternative is disastrous. I am equally happy to underdiagnose colic.  Colic is not harmful and there is no effective treatment.

When it comes to asthma, there is a huge morbidity and mortality associated with this disease.  So while I agree with the study authors about the burden of unnecessary treatment when a child does not have asthma, I believe that the effect of moving our diagnostic goalposts needs to be considered carefully.  Will there be more underdiagnosis as the pendulum swings away from making the diagnosis of asthma on clinical grounds?  That is a real possibility and as far as I can tell no-one has looked at the burden of that change.

The bottom line is that asthma is a diagnosis that can be overdiagnosed and yet underdiagnosis is equally detrimental.  However, without turning to complicated investigations, overdiagnosis and underdiagnosis can both be avoided by considering all the factors that make a diagnosis more or less likely as per the BTS guidelines.

Edward Snelson
Over and under most days
@sailordoctor

This post has been all about diagnosing asthma in the 5-15 year old age group.  If you would like to find out more about the under five year olds you might like to read:
References

  1. Looijmans-van den Akker et Al, Overdiagnosis of asthma in children in primary care: a retrospective analysis, BJGP, 1 March 2016
  2. Draft NICE Guideline for Consultation: Asthma: diagnosis and monitoring of asthma in adults, children and young people
  3. British Thoracic Society /Scottish Intercollegiate Guidelines Network - British guideline on the management of asthma (Quick Reference Guide)





Wednesday, 24 February 2016

Coughing children - Persistent, Perplexing or Paradoxical? Probably not asthma!

In the previous post, I gave a little guidance about patterns of cough in children.  Now, I'll add a little probability to the mix.  After all, good medicine relies heavily on knowing the likelihood of a given disease in a particular scenario.

As someone who occasionally mentions medi-facts that came from articles that I have long since lost track of, I was pleased to be able to re-find an article from Chest (the journal of the American College of Chest Physicians) that I have been using in both practice and teaching.  It asked the question, In persistent cough, can we extrapolate an adult based approach to be used in children? (1)

The resounding answer was no.
Once again, children are shown not to be mini-adults.  Paediatricians everywhere breathe a sigh of relief...

What is perhaps surprising is the number of children with a persistent cough who have evidence that pertussis is the culprit.  In several studies now, the proportion has been shown to about 20-40 % of children who have been coughing for more than two or three weeks.  That large number includes studies that have been done since the ramping up of vaccination campaigns. (2)

Pertussis is a significant illness which still has a mortality of around 3% in unvaccinated babies.  Although less of a menace since the introduction and later improvement of vaccination programs, pertussis is still endemic.  It should be suspected whenever a baby presents with an acute cough.  The typical cough is paroxysmal and there are features that often make the diagnosis more obvious.  Some children get the classic 'whoop' at the end of a coughing paroxysm while some will vomit or have (hopefully brief) apnoeas. It seems from the studies into persistent cough that not all pertussis is obvious acutely.   Early detection reduces both symptoms and transmission.  Guidance on this from the Public Health England can be found here.

So, before thinking that a persistent cough in the absence of wheeze might be asthma think: 'Could this be pertussis?'  The advantages of this are:
  1. There is no test for asthma.  There is a test for pertussis.
  2. As well as diagnosing the index case, you may help to identify the cause of other persistent coughs that are troubling the family and friend of this little one.
  3. You may save a life.  If the pertussis is passed onto (for example) a new born baby this could be devastating.  By recognising pertussis you may prevent transmission.
  4. You avoid the trap of confirmation bias.  If you are tempted to 'try' an inhaler for a few weeks, you may be tricked into believing that it helped when the cough gradually resolves, as it should in time with post-pertussive cough.

Edward Snelson
@sailordoctor

Disclaimer: Of course if we're going to talk probabilities, it's probably a virus...


References

  1. Marchmont et al, Evaluation and Outcome of Young Children With Chronic Cough, Chest Journal, May 2006, Vol 129, No. 5
  2. Wang et al, Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study, BMJ, 2014;348:g3668
  3. Public Health England, Pertussis factsheet for healthcare professionals



Thursday, 31 December 2015

High Voltage - What the diagnosis plus severity means for management of viral wheeze


In the previous post, I concentrated on giving the correct label to the child under the age of five with recurrent episodes of wheeze.  I'd like to pretend that that makes the management simple but I just can't do that.  Not only are the diagnoses confusingly difficult to tell apart sometimes but there are overlaps with treatment options.  So are there actually distinct clinical entities at all?

There are important differences between the two main groups: viral wheeze and asthma/ multi-trigger wheeze.  Once again though, I have to emphasise that viral wheeze is not a lesser diagnosis and can cause life-threatening exacerbations.   It is possible that there are just these two entities and that the viral wheezers need different treatment at the more severe end of the spectrum.  After all, high voltage can do bad things to a circuit.


What is particularly confusing for the generalist is seeing children with a diagnosis like viral episodic wheeze being given a steroid inhaler.  You might be excused for exclaiming WTF!  (Wheeze Treatment Freestyle!)  Surely the whole point is to avoid giving steroid inhalers when the diagnosis is viral wheeze.  Well, as is often the case, yes and no.  Yes, most of the time but no, not always.


The vast majority of children who only get wheeze during a viral illness will do so relatively infrequently.  Also, the episodes in most cases will be mild or moderate and (more importantly) respond well to decent doses of bronchodilators.  The key differences between these children and the smaller number of children who have an atopic cause to their wheeze are that preventative steroid inhalers are not at all likely to prevent or blunt exacerbations of viral wheeze, and the evidence is that systemic steroids do not work for acute episodes.

However, not all viral wheezers were created equally.  Some get frequent exacerbations and some get frequent and severe exacerbations.  There is much debate about phenotypes, genotypes and other big words that don't mean much to the poor three year old who is getting the symptoms.  There is genuine uncertainty about whether there are multiple entities or overlaps and polymorphism.  My  hope is that the paediatric respiratory world find a way to identify the subgroups without over-complicating the list of possible diagnoses.

What we have at the moment is two main groups, with the more severe end of the viral wheeze group being treated in ways that look remarkably similar to the asthma group.  Similar, but not the same.

With the child under five who has an asthma pattern of wheezing, steroid preventer inhalers are a cornerstone of management.  If the diagnosis is recurrent viral wheeze, steroid inhalers are an option when exacerbations are very frequent, especially if severe.  The current advice is that a trial of steroid inhalers should be evaluated and should be stopped if not helpful.  How one knows whether the trial has worked is another question.  If anyone knows a cast iron way of deciding this please get in touch or post a comment.

Edward Snelson
@sailordoctor

Disclaimer: I am not a Respiratory Paediatrician, but sometimes I see so many children with wheeze, it feels like I should be.